AU2004296586B2 - Intranasal compositions - Google Patents

Intranasal compositions Download PDF

Info

Publication number
AU2004296586B2
AU2004296586B2 AU2004296586A AU2004296586A AU2004296586B2 AU 2004296586 B2 AU2004296586 B2 AU 2004296586B2 AU 2004296586 A AU2004296586 A AU 2004296586A AU 2004296586 A AU2004296586 A AU 2004296586A AU 2004296586 B2 AU2004296586 B2 AU 2004296586B2
Authority
AU
Australia
Prior art keywords
granisetron
composition according
chitosan
salt
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004296586A
Other languages
English (en)
Other versions
AU2004296586A2 (en
AU2004296586A1 (en
Inventor
Jonathan Castile
Alan Smith
Peter James Watts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Archimedes Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archimedes Development Ltd filed Critical Archimedes Development Ltd
Publication of AU2004296586A2 publication Critical patent/AU2004296586A2/en
Publication of AU2004296586A1 publication Critical patent/AU2004296586A1/en
Application granted granted Critical
Publication of AU2004296586B2 publication Critical patent/AU2004296586B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2004296586A 2003-12-05 2004-11-30 Intranasal compositions Ceased AU2004296586B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0328186.2 2003-12-05
GBGB0328186.2A GB0328186D0 (en) 2003-12-05 2003-12-05 Intranasal compositions
PCT/GB2004/005043 WO2005056008A1 (en) 2003-12-05 2004-11-30 Intranasal compositions

Publications (3)

Publication Number Publication Date
AU2004296586A2 AU2004296586A2 (en) 2005-06-23
AU2004296586A1 AU2004296586A1 (en) 2005-06-23
AU2004296586B2 true AU2004296586B2 (en) 2010-08-12

Family

ID=29764615

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004296586A Ceased AU2004296586B2 (en) 2003-12-05 2004-11-30 Intranasal compositions

Country Status (26)

Country Link
US (1) US7947257B2 (da)
EP (1) EP1696911B1 (da)
JP (1) JP5103018B2 (da)
KR (1) KR101194593B1 (da)
CN (2) CN102389422A (da)
AT (1) ATE460932T1 (da)
AU (1) AU2004296586B2 (da)
BR (1) BRPI0417350A2 (da)
CA (1) CA2548559C (da)
CY (1) CY1110664T1 (da)
DE (1) DE602004026107D1 (da)
DK (1) DK1696911T3 (da)
ES (1) ES2357607T3 (da)
GB (1) GB0328186D0 (da)
HR (1) HRP20100343T1 (da)
IL (1) IL176132A (da)
ME (1) ME01070B (da)
MX (1) MXPA06006239A (da)
NO (1) NO335348B1 (da)
NZ (1) NZ547848A (da)
PL (1) PL1696911T3 (da)
PT (1) PT1696911E (da)
RS (1) RS51251B (da)
SI (1) SI1696911T1 (da)
WO (1) WO2005056008A1 (da)
ZA (1) ZA200604553B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
CN1758930B (zh) 2003-03-27 2010-06-09 株式会社新日本科学 鼻腔用粉末药剂喷药装置
JP4922762B2 (ja) 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
US7868016B2 (en) * 2005-07-13 2011-01-11 Baxter International Inc. Pharmaceutical formulations of endo-N-(9-methyl-9-azabicyclo[3,3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
WO2007035008A1 (en) * 2005-09-23 2007-03-29 Amphenol Phoenix Co., Ltd. Sliding type opening and closing apparatus for use in portable telephone
CN101325944B (zh) * 2005-10-11 2013-01-16 耶路撒冷希伯来大学伊萨姆研究开发公司 用于鼻部给药的组合物
EP2116264B1 (en) * 2006-12-26 2017-09-27 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
EP2429495A4 (en) * 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS
GB2472327B (en) * 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
KR101368587B1 (ko) * 2010-12-27 2014-03-05 주식회사 삼양바이오팜 오심 또는 구토 방지용 조성물
JP6081102B2 (ja) * 2012-08-10 2017-02-15 テルモ株式会社 安定なグラニセトロン含有水性製剤
US10335398B2 (en) 2015-04-08 2019-07-02 Maxinase Life Sciences Limited Bioadhesive compositions for intranasal administration of granisetron
EP3405174A4 (en) * 2016-01-12 2019-10-30 Nortic Holdings Inc. FORMATION OF BETAETHASONE FOR ORAL SPRAY AND USE THEREOF FOR THE TREATMENT OF ATAXIA
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1452964A (zh) * 2002-04-26 2003-11-05 中国人民解放军军事医学科学院毒物药物研究所 鼻腔喷雾剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2004270A1 (en) 1988-12-29 1990-06-29 William R. Michael Perfume microcapsules for use in granular detergent compositions
CA2042529C (en) 1990-08-10 2002-07-30 Chokyun Rha Polysaccharide article and uses therefor
US5929059A (en) 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
GB9305593D0 (en) 1993-03-18 1993-05-05 Smithkline Beecham Plc Pharmaceuticals
US5897858A (en) * 1994-02-03 1999-04-27 Schering-Plough Healthcare Products, Inc. Nasal spray compositions exhibiting increased retention in the nasal cavity
GB9406171D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
HRP950149A2 (en) * 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
GB9414966D0 (en) 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
GB9700624D0 (en) 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
GB9713980D0 (en) 1997-07-03 1997-09-10 Danbiosyst Uk New conjugates
US20020132803A1 (en) * 2001-01-05 2002-09-19 Mahendra Dedhiya Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
JP2002255795A (ja) * 2001-02-26 2002-09-11 Teijin Ltd 経鼻投与用組成物
US20030044356A1 (en) * 2001-04-20 2003-03-06 Jin Auh Composition for nasal solution sprays having effective component of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one)
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
CN1332664C (zh) * 2002-04-26 2007-08-22 中国人民解放军军事医学科学院毒物药物研究所 鼻粉剂
GB0329918D0 (en) 2003-12-24 2004-01-28 West Pharm Serv Drug Res Ltd Intranasal compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1452964A (zh) * 2002-04-26 2003-11-05 中国人民解放军军事医学科学院毒物药物研究所 鼻腔喷雾剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ILLUM: "Nasal Drug Delivery: New Developments and Strategies" Drug Discovery Today, vol. 7(23), pp. 1184 - 1189. *

Also Published As

Publication number Publication date
IL176132A0 (en) 2006-10-05
ZA200604553B (en) 2009-09-30
DK1696911T3 (da) 2010-06-28
SI1696911T1 (sl) 2010-06-30
CA2548559A1 (en) 2005-06-23
DE602004026107D1 (de) 2010-04-29
CN1901905A (zh) 2007-01-24
NO20062548L (no) 2006-08-15
AU2004296586A2 (en) 2005-06-23
JP2007513129A (ja) 2007-05-24
US7947257B2 (en) 2011-05-24
MXPA06006239A (es) 2006-08-23
HRP20100343T1 (hr) 2010-11-30
IL176132A (en) 2010-12-30
EP1696911B1 (en) 2010-03-17
NZ547848A (en) 2009-04-30
US20050142073A1 (en) 2005-06-30
ATE460932T1 (de) 2010-04-15
ME01070B (me) 2012-10-20
RS51251B (sr) 2010-12-31
GB0328186D0 (en) 2004-01-07
CY1110664T1 (el) 2015-06-10
KR20060126532A (ko) 2006-12-07
BRPI0417350A2 (pt) 2009-03-10
EP1696911A1 (en) 2006-09-06
KR101194593B1 (ko) 2012-10-25
CN102389422A (zh) 2012-03-28
NO335348B1 (no) 2014-11-24
PT1696911E (pt) 2010-04-29
CA2548559C (en) 2013-09-03
AU2004296586A1 (en) 2005-06-23
WO2005056008A1 (en) 2005-06-23
ES2357607T3 (es) 2011-04-28
JP5103018B2 (ja) 2012-12-19
PL1696911T3 (pl) 2010-08-31

Similar Documents

Publication Publication Date Title
NO335348B1 (no) Blanding for nasal administrering omfattende granisetron, anvendelse av granisetron og anordning for nasal administrering.
US9078814B2 (en) Intranasal spray device containing pharmaceutical composition
EP0865789B1 (en) Pharmaceutical compositions for intranasal administration of dihydroergotamine
AU2008326220A2 (en) Intranasal compositions
US20220331289A1 (en) Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
US8034371B2 (en) Intranasal compositions
KR101173696B1 (ko) 플루오로퀴놀론의 국소 적용에 의한 호흡 기관의 세균성질환의 치료
WO2012110462A1 (en) Liquid propellant-free formulation comprising an antimuscarinic drug

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 07 JUN 2006

FGA Letters patent sealed or granted (standard patent)
GD Licence registered

Name of requester: ALMAC DISCOVERY LIMITED

MK14 Patent ceased section 143(a) (annual fees not paid) or expired